» Articles » PMID: 19326507

The Role of Indoor Allergens in the Development of Asthma

Overview
Date 2009 Mar 28
PMID 19326507
Citations 53
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose Of Review: Asthma prevalence has markedly increased over the past 30 years. Although atopy and exposure to environmental allergens are known to exacerbate asthma, recent literature supports a causal role of indoor allergens in disease development.

Recent Findings: High-risk birth cohorts continue to point to atopy as the main risk factor for developing asthma. Exposure to perennial allergens has also been linked to the development of asthma, though with less consistency. Intervention at the level of allergen exposure and allergic immune response is promising.

Summary: The current model of atopic asthma, the predominant phenotype, incorporates genetic and environmental factors in the development of disease. Although genetic factors are less malleable, the environmental component lends itself to analysis and modification.For many, the development of asthma starts with allergen exposure leading to atopic sensitization and subsequent disease. Several studies support the progression from exposure to sensitization with the potential of extremely high levels of exposure leading to tolerance. Likewise, the progression from atopy to asthma is well documented,especially in genetically predisposed children. Recent intervention trials confirm these findings and begin to show promise for the prevention of asthma by interrupting the allergen exposure==>allergen sensitization==>atopic asthma pathway.

Citing Articles

Microscopic Menaces: The Impact of Mites on Human Health.

Linn C, OMalley A, Khatri K, Wright E, Sebagh D, Grbic M Int J Mol Sci. 2024; 25(7).

PMID: 38612486 PMC: 11011512. DOI: 10.3390/ijms25073675.


Causal relationship between and allergic asthma: a two-sample Mendelian randomization study.

Wan W, Qiu Y, Huang X, Ren Y, Peng A, Yang C Front Microbiol. 2023; 14:1190765.

PMID: 37869656 PMC: 10587591. DOI: 10.3389/fmicb.2023.1190765.


Immunomodulatory effects of modified Liu-Wei-Di-Huang-Wan Traditional Chinese medicine on allergic asthmatic mice.

Tsai J, Yen C, Hsu C, Yu S, Chen C, Liao E Allergy Asthma Clin Immunol. 2023; 19(1):35.

PMID: 37101296 PMC: 10134635. DOI: 10.1186/s13223-023-00792-5.


Precision Medicine in Mite Allergic Rhinitis.

Gonzalez-Perez R, El-Qutob D, Letran A, Matheu V Front Allergy. 2022; 2:724727.

PMID: 35387006 PMC: 8974769. DOI: 10.3389/falgy.2021.724727.


Treatment outcome clustering patterns correspond to discrete asthma phenotypes in children.

Banic I, Lovric M, Cuder G, Kern R, Rijavec M, Korosec P Asthma Res Pract. 2021; 7(1):11.

PMID: 34344475 PMC: 8330019. DOI: 10.1186/s40733-021-00077-x.


References
1.
Klepeis N, Nelson W, Ott W, Robinson J, Tsang A, Switzer P . The National Human Activity Pattern Survey (NHAPS): a resource for assessing exposure to environmental pollutants. J Expo Anal Environ Epidemiol. 2001; 11(3):231-52. DOI: 10.1038/sj.jea.7500165. View

2.
van Strien R, Koopman L, Kerkhof M, Oldenwening M, de Jongste J, Gerritsen J . Mattress encasings and mite allergen levels in the Prevention and Incidence of Asthma and Mite Allergy study. Clin Exp Allergy. 2003; 33(4):490-5. DOI: 10.1046/j.1365-2222.2003.01626.x. View

3.
Chan-Yeung M, Ferguson A, Watson W, Dimich-Ward H, Rousseau R, Lilley M . The Canadian Childhood Asthma Primary Prevention Study: outcomes at 7 years of age. J Allergy Clin Immunol. 2005; 116(1):49-55. DOI: 10.1016/j.jaci.2005.03.029. View

4.
Marks G, Mihrshahi S, Kemp A, Tovey E, Webb K, Almqvist C . Prevention of asthma during the first 5 years of life: a randomized controlled trial. J Allergy Clin Immunol. 2006; 118(1):53-61. DOI: 10.1016/j.jaci.2006.04.004. View

5.
Munir A, Kjellman N, Bjorksten B . Exposure to indoor allergens in early infancy and sensitization. J Allergy Clin Immunol. 1997; 100(2):177-81. DOI: 10.1016/s0091-6749(97)70221-5. View